A L Barry|P C Fuchs|S D Brown - JoVE Visualize

Showing results (111-120 of 586) with videos related to

Pageof 59

Sort By:

American Journal of Clinical Pathology|December 1, 1978

Reassessment of the "class" concept of disk susceptibility testing. Cephalothin disks versus minimal inhibitory concentrations with eleven cephalosporinsA L Barry, C Thornsberry, R N Jones, et al.

Diagnostic Microbiology and Infectious Disease|March 1, 1995

Tentative criteria for determining the in vitro susceptibilities of Haemophilus influenzae, including quality control parameters, to two fluoroquinolones (grepafloxacin and PD 131628)D L Sewell, A L Barry, S D Allen, et al.

Antimicrobial Agents and Chemotherapy|July 1, 1977

Cefuroxime, a new parenteral cephalosporin: collaborative in vitro susceptibility comparison with cephalothin against 5,887 clinical bacterial isolatesR N Jones, P C Fuchs, T L Gavan, et al.

The American Journal of the Medical Sciences|November 1, 1977

Ticarcillin: a collaborative in vitro comparison with carbenicillin against over 9,000 clinical bacterial isolatesP C Fuchs, T L Gavan, E H Gerlach, et al.

Journal of Clinical Microbiology|January 1, 1987

Quality control limits for microdilution susceptibility tests with norfloxacinA L Barry, T L Gavan, L W Ayers, et al.

The Journal of Antibiotics|December 1, 1977

Piperacillin (T-1220), a new semisynthetic penicillin: in vitro antimicrobial activity comparison with carbenicillin, ticarcillin, ampicillin, cephalothin, cefamandole and cefoxitinR N Jones, C Thornsberry, A L Barry, et al.

Diagnostic Microbiology and Infectious Disease|January 1, 1988

Antimicrobial activity of U-76,252 (CS-807), a new orally administered cephalosporin ester, including recommendations for MIC quality controlR N Jones, A L Barry, M Pfaller, et al.

The Journal of Antibiotics|July 1, 1977

BL-S786, a new parenteral cephalosporin. II. In vitro antimicrobial activity comparison with six related cephalosporinsR N Jones, C Thornsberry, A L Barry, et al.

Antimicrobial Agents and Chemotherapy|December 1, 1981

Cefmenoxime (SCE-1365), a new cephalosporin: in vitro activity, comparison with other antimicrobial agents, beta-lactamase stability, and disk diffusion testing with tentative interpretive criteriaP C Fuchs, R N Jones, C Thornsberry, et al.

Journal of Clinical Microbiology|January 1, 1989

Quality control limits for the standard anaerobic reference agar dilution susceptibility test procedure of the National Committee for Clinical Laboratory StandardsA L Barry, P C Fuchs, S D Allen, et al.

Pageof 59

Showing results (111-120 of 586) with videos related to

Sort By:

Pageof 59

American Journal of Clinical Pathology|December 1, 1978

Reassessment of the "class" concept of disk susceptibility testing. Cephalothin disks versus minimal inhibitory concentrations with eleven cephalosporinsA L Barry, C Thornsberry, R N Jones, et al.

Diagnostic Microbiology and Infectious Disease|March 1, 1995

Tentative criteria for determining the in vitro susceptibilities of Haemophilus influenzae, including quality control parameters, to two fluoroquinolones (grepafloxacin and PD 131628)D L Sewell, A L Barry, S D Allen, et al.

Antimicrobial Agents and Chemotherapy|July 1, 1977

Cefuroxime, a new parenteral cephalosporin: collaborative in vitro susceptibility comparison with cephalothin against 5,887 clinical bacterial isolatesR N Jones, P C Fuchs, T L Gavan, et al.

The American Journal of the Medical Sciences|November 1, 1977

Ticarcillin: a collaborative in vitro comparison with carbenicillin against over 9,000 clinical bacterial isolatesP C Fuchs, T L Gavan, E H Gerlach, et al.

Journal of Clinical Microbiology|January 1, 1987

Quality control limits for microdilution susceptibility tests with norfloxacinA L Barry, T L Gavan, L W Ayers, et al.

The Journal of Antibiotics|December 1, 1977

Piperacillin (T-1220), a new semisynthetic penicillin: in vitro antimicrobial activity comparison with carbenicillin, ticarcillin, ampicillin, cephalothin, cefamandole and cefoxitinR N Jones, C Thornsberry, A L Barry, et al.

Diagnostic Microbiology and Infectious Disease|January 1, 1988

Antimicrobial activity of U-76,252 (CS-807), a new orally administered cephalosporin ester, including recommendations for MIC quality controlR N Jones, A L Barry, M Pfaller, et al.

The Journal of Antibiotics|July 1, 1977

BL-S786, a new parenteral cephalosporin. II. In vitro antimicrobial activity comparison with six related cephalosporinsR N Jones, C Thornsberry, A L Barry, et al.

Antimicrobial Agents and Chemotherapy|December 1, 1981

Cefmenoxime (SCE-1365), a new cephalosporin: in vitro activity, comparison with other antimicrobial agents, beta-lactamase stability, and disk diffusion testing with tentative interpretive criteriaP C Fuchs, R N Jones, C Thornsberry, et al.

Journal of Clinical Microbiology|January 1, 1989

Quality control limits for the standard anaerobic reference agar dilution susceptibility test procedure of the National Committee for Clinical Laboratory StandardsA L Barry, P C Fuchs, S D Allen, et al.

Pageof 59